| INTERVET INTERNATIONAL B.V. Patent applications |
| Patent application number | Title | Published |
|---|
| 20120122808 | MACROLIDE SYNTHESIS PROCESS AND SOLID-STATE FORMS - Described are methods for making macrolides, and, in particular, a method for making optionally substituted 20,23-dipiperidinyl-5-O-mycaminosyl-tylonolide and derivatives thereof, as well as uses of macrolides to make medicaments, methods of treatment using macrolides, and methods for making intermediates that, among other uses, may be used to make macrolides. Also described are solvated and non-solvated crystalline forms of 20,23-dipiperidinyl-5-O-mycaminosyl-tylonolide, as well as methods for making such crystalline forms, medicaments comprising (or derived from) such crystalline forms, methods for making medicaments comprising (or derived from) such crystalline forms, methods of treatment using such crystalline forms, and kits comprising such crystalline forms. | 05-17-2012 |
| 20110311586 | Materials and methods for respiratory disease control in canines - The subject invention pertains to isolated influenza virus that is capable of infecting canids and causing respiratory disease in the canid. The subject invention also pertains to compositions and methods for inducing an immune response against an influenza virus of the present invention. The subject invention also pertains to compositions and methods for identifying a virus of the invention and diagnosing infection of an animal with a virus of the invention. | 12-22-2011 |
| 20110135659 | Fish Vaccine - A salmonid alphavirus polypeptide comprising an epitope capable of inducing a virus neutralizing immune response, nucleic acids encoding the polypeptide, a vaccine comprising the polypeptide and a method of producing salmonid alphavirus neutralizing antibodies. | 06-09-2011 |
| 20110123571 | USE OF BACTERIUM FOR MANUFACTURE OF A VACCINE - The present inventon relates to the use of live attenuated bacteria for the manufacture of a vaccine for submucosal administration. | 05-26-2011 |
| 20110123565 | Structural Proteins of Fish Pancreatic Disease Virus and Uses Thereof - The present invention relates to the structural proteins of the causative agent of Pancreatic Disease in fish, nucleotide sequences encoding said proteins, vaccines comprising said proteins or nucleotide sequences and diagnostic kits comprising said proteins or nucleotide sequences. | 05-26-2011 |
| 20110070256 | Vaccine Antigens from Piscirickettsia Salmonis - The present invention discloses novel proteins, e.g., antigens, from | 03-24-2011 |
| 20110021506 | ANTHELMINTIC AGENTS AND THEIR USE - This invention is directed to compounds and salts that are generally useful as anthelmintic agents or as intermediates in processes for making anthelmintic agents. This invention also is directed to processes for making the compounds and salts, pharmaceutical compositions and kits comprising the compounds and salts, uses of the compounds and salts to make medicaments, and treatments comprising the administration of the compounds and salts to animals in need of the treatments. | 01-27-2011 |
| 20110014232 | CHIMERIC FOOT AND MOUTH DISEASE VIRUSES - Foot and mouth disease (FMD) viruses which are able to grow on BHK-21 cells in suspension are described herein. The new viruses are recombinant chimeric viruses formed by replacing the outer capsid coding region of a first FMDV strain, which has previously been shown to be an effective vaccine strain, with the outer capsid coding region of a second FMDV strain. The outer capsid coding region of the second FMDV strain is also modified to introduce a heparan sulphate proteoglycan (HSPG) binding site. The chimeric viruses are then used as seed viruses in the production of inactivated vaccine antigens which have been tailored for specific outbreak situations or locality. The invention also relates to the product of expression of the chimeric FMD viruses and to uses therefor, such as to form antigenic, immunological or vaccine compositions for prevention of FMD. | 01-20-2011 |
| 20100324125 | Proteins derived from white spot syndrome virus and uses thereof - Embodiments of the present invention generally relate to proteins derived from white spot syndrome virus, nucleic acid sequences encoding them, and their use in the manufacture of a vaccine for prophylaxis and/or treatment of white spot syndrome in crustaceans. | 12-23-2010 |
| 20100233208 | Methods of Treating and Preventing Neurological Symptoms Caused by Avian Reovirus and Novel Associated Characteristics - Embodiments of the present invention generally relate to novel methods for the treatment and/or prevention of neurological symptoms caused by an avian reovirus, enteric reovirus strain (ERS), and associated characteristics. Other embodiments generally comprise and immunogenic composition or vaccine comprising an ERS for the treatment and/or prevention of neurological symptoms. | 09-16-2010 |
| 20100179205 | Composition for Enhanced Antiparasitic Activity - The invention relates to antiparasitic compositions comprising a combination of atipamezole or its pharmaceutically acceptable salt and amitraz and their use in a method to control ectoparasite infestations on animals. | 07-15-2010 |
| 20100166803 | EIMERIA VACCINE FOR TURKEYS - The present invention discloses a vaccine that provides protection to turkeys from coccidiosis, and methods of making and using the vaccine alone, or in combinations with other protective agents. In addition, the present invention discloses PCR primer sets that are useful in identifying the species of | 07-01-2010 |
| 20100111997 | Multi component vaccine containing clostridial and non-clostridial organisms in a low dose - Disclosed herein is a multicomponent low dose vaccine comprising a safe and immunogenically effective combination of a protective antigen component or components of clostridial organism, a protective antigen component of a non-clostridial organism and an adjuvant. | 05-06-2010 |
| 20100062025 | Use of Clostridium perfringens type C bacterium for the manufacture of a vaccine - The present invention relates to the use of a vaccine comprising | 03-11-2010 |
| 20100028383 | Chemically defined stabiliser - The present invention relates to a stabiliser composition comprising an amino acid, and a sugar wherein all compounds are chemically defined; to a vaccine composition comprising such a stabiliser composition and a biological molecule and/or a micro-organism; to a method for preparing a pharmaceutical composition comprising admixing such a stabiliser composition with a biological molecule and/or a micro-organism; to the use of such a stabiliser composition, and of vaccines prepared therewith. | 02-04-2010 |
| 20100022490 | Zilpaterol Enantiomer Compositions and Methods of Making and Using Such Compositions - This invention is directed generally to zilpaterol enantiomer compositions and, in particular, to compositions comprising the 6R,7R zilpaterol enantiomer. This invention is also directed to processes for making such compositions; methods for using such compositions to, for example, increase the rate of weight gain, improve feed efficiency, and/or increase carcass leanness in livestock, poultry, and/or fish; and uses of such compositions to make medicaments. This invention is further directed to methods for determining the absolute configurations of zilpaterol enantiomers. | 01-28-2010 |
| 20090304737 | Vaccine Against Mycoplasma PRRSV - The present invention relates to the use of an immunogenic dose of immunogenic material of | 12-10-2009 |
| 20090275662 | Injectable veterinary composition - Injectable veterinary composition comprising a fluorinated chloramphenicol or thiamphenicol derivative and a solvent system comprising an ether of 1,2-ethanediol oligo- or polymers, and a pyrrolidone solvent. | 11-05-2009 |
| 20090270507 | Concentrated Liquid Thyroid Hormone Composition - This invention is directed generally to a liquid pharmaceutical composition comprising at least one thyroid hormone (particularly a composition further comprising at least one cyclodextrin compound), a process for making such a composition and a method of using such a composition to treat a condition associated with impaired thyroid hormone function. | 10-29-2009 |
| 20090246223 | Inactivated Chimeric Vaccines and Related Methods of Use - Embodiments of the present invention generally provide an inactivated chimeric virus vaccine and/or immunogenic composition for the treatment or prevention of viral infection. Further, various other embodiments of the present invention generally relate to methods of preventing and treating virus infection in such animals with the inactivated vaccine and/or immunogenic composition. Other embodiments comprise methods of preparing a vaccine or immunogenic composition for the treatment or prevention of viral infection in such animals. | 10-01-2009 |
| 20090238844 | Porcine reproductive and respiratory syndrome virus strains and compositions - This invention relates to two attenuated strains of porcine reproductive and respiratory syndrome virus (PRRSV) and immunogenic compositions comprising one or more strains of attenuated porcine reproductive and respiratory syndrome virus (PRRSV). | 09-24-2009 |
| 20090232846 | Pestivirus mutant for use in a vaccine - The present invention comprises new pestivirus mutants, characterized in that the mutants are based on a cp strain of the virus wherein part of the gene sequence encoding the Npro region is deleted, except that the deleted part does not encompass the coding sequence for the N-terminal twelve amino acids of the Npro protein. Preferably the pestivirus is the Bovine Viral Diarrhea Virus (BVDV). It was found that a mutant according to the invention is a safe and efficient vaccine candidate. | 09-17-2009 |
| 20090181906 | Combination Therapies using Melengestrol Acetate and Zilpaterol or its Salts - This invention generally relates to a method for promoting growth and increasing feed utilization efficiency in animals, and, more specifically, to combinations comprising zilpaterol (and salts thereof) and melengestrol acetate. Included within this invention are treatment methods comprising the administration of such combinations to animals, compositions comprising such combinations, uses of such combinations to prepare medicaments, and kits for using such combinations. | 07-16-2009 |
| 20090162388 | Fish Vaccine - The present invention relates to veterinary immunology, namely to the immunological response of fish to a virus. More specifically, the invention provides an epitope of salmonid alphaviruses which epitope is capable of inducing a virus neutralising immune response. In particular the invention relates to a polypeptide comprising a certain amino acid sequence, a protein comprising such polypeptide, to a carrier comprising such protein, and to a method of producing antibodies. Further the invention relates to a nucleic acid encoding such polypeptide or such protein, and to a carrier comprising such a nucleic acid. Also, the invention relates to a vaccine and a diagnostic kit comprising such a polypeptide, protein, carrier, or nucleic acid. | 06-25-2009 |
| 20090131369 | Novel Benzimidazole(Thio)Carbamates with Antiparasitic Activity and the Synthesis Thereof - This invention relates to benzimidazole carbamates and (thio)carbamates corresponding to Formula I: | 05-21-2009 |
| 20090130142 | Streptococcus Phocae Vaccine - The present invention relates to the use of bacteria of the species | 05-21-2009 |
| 20090068212 | Proteins derived from white spot syndrome virus and uses thereof - Embodiments of the present invention generally relate to proteins derived from white spot syndrome virus, nucleic acid sequences encoding them, and their use in the manufacture of a vaccine for prophylaxis and/or treatment of white spot syndrome in crustaceans. | 03-12-2009 |
| 20090053262 | Combination vaccine for poultry - The present invention relates to a combination vaccine for the protection of poultry against | 02-26-2009 |
| 20090042815 | Macrolide Synthesis Process and Solid-State Forms - This invention relates to a method for making macrolides, and, in particular, a method for making optionally substituted 20,23-dipiperidinyl-5-O-mycaminosyl-tylonolide and derivatives thereof, as well as uses of macrolides to make medicaments, methods of treatment using macrolides, and methods for making intermediates that, inter alia, may be used to make macrolides. This invention also relates to solvated and non-solvated crystalline forms of 20,23-dipiperidinyl-5-O-mycaminosyl-tylonolide, as well as methods for making such crystalline forms, medicaments comprising (or derived from) such crystalline forms, methods for making medicaments comprising (or derived from) such crystalline forms, methods of treatment using such crystalline forms, and kits comprising such crystalline forms. | 02-12-2009 |
| 20090017048 | Novel Brachyspira hyodysenteriae vaccine - The present invention relates to nucleic acid sequences encoding a 61 kD and a 20 kD | 01-15-2009 |
| 20080318919 | Cefquinome Compositions and Methods of Their Use - This invention is directed generally to cefquinome compositions, processes for making such compositions, uses of such compositions to make medicaments, kits for making such compositions, and methods for using such compositions and kits to treat infections. | 12-25-2008 |
| 20080292659 | Prime Boost Vaccine for the Protection of Equines Against Equine Influenza - The present invention is concerned with vaccinating equines against the equine influenza virus (EIV). | 11-27-2008 |
| 20080248061 | Pcv-2 Vaccine - The present invention relates to a vaccine against porcine circovirus type 2 (PCV-)2 and a method for the manufacture of such a vaccine, for protecting piglets against PCV-2 infection. | 10-09-2008 |
| 20080241179 | Structural proteins of fish pancreatic disease virus and uses thereof - The present invention relates to the structural proteins of the causative agent of Pancreatic Disease in fish, nucleotide sequences encoding said proteins, vaccines comprising said proteins or nucleotide sequences and diagnostic kits comprising said proteins or nucleotide sequences. | 10-02-2008 |
| 20080233138 | Coccidiosis Poultry Vaccine - This invention relates to novel | 09-25-2008 |
| 20080213304 | Methods of Treating and Preventing Neurological Symptons Caused by Avian Reovirus and Novel Associated Characteristics - Embodiments of the present invention generally relate to novel methods for the treatment and/or prevention of neurological symptoms caused by an avian reovirus, enteric reovirus strain (ERS), and associated characteristics. Other embodiments generally comprise and immunogenic composition or vaccine comprising an ERS for the treatment and/or prevention of neurological symptoms. | 09-04-2008 |
